Literature DB >> 16190773

Unambiguous synthesis and prophylactic antimalarial activities of imidazolidinedione derivatives.

Quan Zhang1, Jian Guan, John Sacci, Arba Ager, William Ellis, Wilbur Milhous, Dennis Kyle, Ai J Lin.   

Abstract

WR182393, a guanidinoimidazolidinedione derivatives with potent causal prophylactic antimalarial activity by intramuscular injection, was previously prepared by treatment of chloroproguanil and diethyl oxalate, yielding a mixture of two closely related isomers. Poor solubility of the mixture made the separation and purification impossible. To overcome the separation problem, new and facile unambiguous syntheses of the two active components were reported. The new synthetic methods facilitate the synthesis of not only the active components, but also their derivatives. To search for compounds with good oral efficacy, a series of carbamate derivatives of the active components were prepared by the new procedure, many of which showed profound causal prophylactic antimalarial activity against Plasmodium yoelii in mouse by oral administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190773     DOI: 10.1021/jm0504252

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

Review 2.  An epigrammatic status of the 'azole'-based antimalarial drugs.

Authors:  Mousmee Sharma; Parteek Prasher
Journal:  RSC Med Chem       Date:  2019-12-23

3.  Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition.

Authors:  Elaine Ballinger; John Mosior; Travis Hartman; Kristin Burns-Huang; Ben Gold; Roxanne Morris; Laurent Goullieux; Isabelle Blanc; Julien Vaubourgeix; Sophie Lagrange; Laurent Fraisse; Stéphanie Sans; Cedric Couturier; Eric Bacqué; Kyu Rhee; Sarah M Scarry; Jeffrey Aubé; Guangbin Yang; Ouathek Ouerfelli; Dirk Schnappinger; Thomas R Ioerger; Curtis A Engelhart; Jennifer A McConnell; Kathrine McAulay; Allison Fay; Christine Roubert; James Sacchettini; Carl Nathan
Journal:  Science       Date:  2019-02-01       Impact factor: 47.728

4.  A plant-derived morphinan as a novel lead compound active against malaria liver stages.

Authors:  Maëlle Carraz; Akino Jossang; Jean-François Franetich; Anthony Siau; Liliane Ciceron; Laurent Hannoun; Robert Sauerwein; François Frappier; Philippe Rasoanaivo; Georges Snounou; Dominique Mazier
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

5.  In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas.

Authors:  Samantha Ottavi; Sarah M Scarry; John Mosior; Yan Ling; Julia Roberts; Amrita Singh; David Zhang; Laurent Goullieux; Christine Roubert; Eric Bacqué; H Rachel Lagiakos; Jeremie Vendome; Francesca Moraca; Kelin Li; Andrew J Perkowski; Remya Ramesh; Matthew M Bowler; William Tracy; Victoria A Feher; James C Sacchettini; Ben S Gold; Carl F Nathan; Jeffrey Aubé
Journal:  J Med Chem       Date:  2022-01-19       Impact factor: 8.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.